News

2025

Quest for Growth cannot yet turn the tide in 2024

30 January 2025

QfG commits € 12.5 million to Capricorn Healthtech Fund II

9 January 2025

NAV per share on 31/12/2024: € 7.17

9 January 2025

2024

NAV per share on 30/11/2024: € 7.11

5 December 2024

Takeover bid on Nexus AG, a stock from QfG’s portfolio

27 November 2024

NAV per share on 31/10/2024: € 7.19

7 November 2024

Business update 30 September 2024

24 October 2024

NAV per share on 30/09/2024: € 7.37

3 October 2024

NAV per share on 31/08/2024: € 7.45

5 September 2024

NAV per share on 31/07/2024: € 7.46

8 August 2024

Quest for Growth participates in € 60 million funding round for Confo Therapeutics, advancing innovative therapies

26 July 2024

Semi-annual report 30 June 2024

25 July 2024

• 1
• 2
• 3
• 4
• 5
• ...
• 11